Quantcast

Neuromonics Signs Reselling Agreement with Elite Hearing Network

August 13, 2014

Tinnitus Company Extends Special Pricing, Support on Devices to Help Ringing in the Ears

Westminster, CO (PRWEB) August 13, 2014

Neuromonics, Inc., manufacturer and distributor of clinically proven tinnitus treatment devices, has signed a new reseller agreement with Elite Hearing Network.

Elite will offer special pricing, marketing, training and other support for all Neuromonics products to its network of 800 clinicians through the agreement. Elite provides business support services to independent hearing care practices throughout the United States. The agreement extends a relationship Neuromonics has had with Elite since 2012, according to Eula Adams, CEO of Neuromonics.

“The new agreement further builds on a strong relationship between Elite and Neuromonics,” says Adams. “Elite Hearing is a critical link to Neuromonics’ ability to deliver the miracle of tinnitus relief to tinnitus sufferers.”

Neuromonics manufactures and distributes clinically proven, FDA-cleared medical devices to treat tinnitus, the condition often described as buzzing, ringing, hissing, humming, roaring, whistling or "ringing in the ears” that someone hears in the absence of any external sound. Globally, tinnitus affects an estimated 10-15 percent of the population. In the United States alone, more than 50 million people suffer from the condition, according to the American Tinnitus Association. Usually brought on by exposure to loud noise, tinnitus is especially significant in the military, with more than 34 percent of returning veterans from Iraq and Afghanistan suffering from the condition.

Neuromonics products use calming, relaxing music embedded with a neural stimulus that interacts with the tinnitus perception, explains Adams. The music engages the auditory pathways to promote neural plastic changes. Over time, these changes help the brain to filter out the tinnitus perception, reducing tinnitus disturbance and providing long-term relief from symptoms. The compact devices are simple to use, function much like familiar consumer music players, and fit easily into patients’ lifestyles.

Neuromonics, Inc. (http://www.neuromonics.com)

Based in Westminster, Colo., Neuromonics, Inc., manufactures and distributes clinically proven, FDA-cleared medical devices to treat tinnitus. The patented and clinically proven Oasis, working the Neuromonics Tinnitus Treatment, provides long-term treatment and significant relief for those with severe tinnitus. The Haven, with the ability to program and individualize hearing profiles, is a management tool offering situational relief for tinnitus symptoms. The Sanctuary, also a management tool, works with pre-programmed profiles for on-demand relief.

With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus. More than 400 licensed, trained audiologists across four continents administer the Neuromonics Tinnitus Treatment. Neuromonics news includes segments on national media including “The Doctors” and CNN.

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/08/prweb12087827.htm


Source: prweb



comments powered by Disqus